Introduction
Zoledronic acid, sold under the trade name Zometa, is a bisphosphonate used to manage bone-related complications in patients with advanced cancer. It is particularly effective for treating bone metastases in prostate cancer and preventing skeletal-related events (SREs), such as fractures and spinal cord compression.
Purpose
- Treats bone metastases in prostate cancer to reduce complications.
- Prevents and manages skeletal-related events (SREs).
- Slows bone resorption, reducing the risk of fractures and pain.
How It Works
Zoledronic acid inhibits osteoclast activity, the cells responsible for breaking down bone tissue. This reduces bone resorption and strengthens the bone structure, helping prevent complications caused by cancer spreading to the bones.
Usage
- Administered as an intravenous infusion, typically every 4 weeks.
- Patients are advised to maintain adequate hydration before and after the infusion.
- Calcium and vitamin D supplementation is recommended to support bone health.
Considerations
- Common side effects include mild flu-like symptoms, fatigue, and nausea.
- Rare but serious side effects include osteonecrosis of the jaw (ONJ) and kidney dysfunction; dental evaluations and renal function tests are recommended before starting therapy.
- Monitoring of calcium levels and overall kidney health is essential during treatment.
At Crossroads Urology
At Crossroads Urology, Zoledronic acid is used to protect bone health in patients with advanced prostate cancer and bone metastases. Our providers tailor treatment plans to each patient’s needs, ensuring safe and effective care.
Conclusion
Zoledronic acid [Zometa] is a powerful bisphosphonate therapy for managing bone complications in advanced prostate cancer, improving quality of life and reducing the risk of fractures. Contact Crossroads Urology today to learn more about this treatment and how it can support your cancer care.